or Try an Advanced Search...

    Cataract Surgery Stocks List

    Symbol Grade Name % Change
    ABT D Abbott Laboratories 0.30
    BLCO F Bausch + Lomb Corporation -5.50
    OCUL D Ocular Therapeutix, Inc. 5.91
    RXST A RxSight, Inc. 8.77
    STAA B STAAR Surgical Company -2.76
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Cataracts Eye Glaucoma Treatment Of Glaucoma Vision Eye Surgery Hypertension Inflammation Lens Care Products Ocular Hypertension Ophthalmology Pain Allergic Conjunctivitis Allergology Aspheric Lens Astigmatism Blood Glucose Monitoring Cancer Cholestasis Clinical Trial

    Related ETFs - A few ETFs which own one or more of the above listed Cataract Surgery stocks.

    Symbol Grade Name Weight
    IHI C iShares U.S. Medical Devices ETF 16.59
    PJP B PowerShares Dynamic Pharmaceuticals 5.44
    XHE C SPDR S&P Health Care Equipment 5.37
    HART A IQ Healthy Hearts ETF 4.61
    VIRS B Pacer BioThreat Strategy ETF 4.47
    View all Cataract Surgery ETFs...
    Compare ETFs
    Compare HART to VIRS Compare IHI to PJP Compare XHE to HART

        Cataract Surgery Stocks Recent News

        Date Stock Title
        May 1 RXST RxSight, Inc. to Present at the Bank of America Healthcare Conference
        May 1 BLCO Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript
        May 1 STAA STAAR Surgical Company's (NASDAQ:STAA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
        May 1 ABT Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
        May 1 BLCO Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening
        May 1 OCUL Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
        May 1 BLCO Bausch + Lomb GAAP EPS of -$0.48, revenue of $1.1B
        May 1 STAA STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
        May 1 BLCO Bausch + Lomb Announces First-Quarter 2024 Results
        May 1 RXST RxSight: Promising Technology, Uncertain Profitability - A Hold Recommendation
        Apr 30 BLCO Bausch + Lomb Q1 2024 Earnings Preview
        Apr 30 ABT PBH vs. ABT: Which Stock Is the Better Value Option?
        Apr 29 ABT Abbott gets FDA approval for Esprit BTK stent for PAD
        Apr 29 ABT Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
        Apr 29 STAA STAAR Surgical to Report First Quarter Results on May 7, 2024
        Apr 29 BLCO Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
        Apr 29 BLCO Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 ABT 2 Beaten-Down Dividend Stocks to Buy and Hold Forever
        Apr 26 ABT ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
        Apr 25 STAA Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
        Related Industries: Biotechnology Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Cataracts Eye Glaucoma Treatment Of Glaucoma Vision Eye Surgery Hypertension Inflammation Lens Care Products Ocular Hypertension Ophthalmology Pain Allergic Conjunctivitis Allergology Aspheric Lens Astigmatism Blood Glucose Monitoring Cancer Cholestasis Clinical Trial
        Cataract Surgery

        Cataract surgery is a procedure to remove the cloudy lens in the eye and replace it with an artificial lens. It is a very common and safe procedure that can help improve vision and reduce the need for glasses or contact lenses. During the procedure, the eye surgeon will make a small incision in the eye and use a special tool to break up the cloudy lens and remove it. The artificial lens is then inserted and the incision is closed.

        Browse All Tags